In the latest episode of Dr. Phil Primetime, the show focuses on America’s reliance on China for pharmaceutical drugs and how it impacts the nation’s health and security. This episode will air on Merit Street Media on Thursday, August 15, 2024, at 8:00 PM. The episode highlights the ongoing national drug shortage, which has left millions struggling to access the medications they need.
The story of 29-year-old Samantha, who has relied on ADHD medication for 14 years but now faces challenges filling her prescription, is featured. This situation is not unique, as independent pharmacist Phil shares that he regularly encounters dozens of prescriptions he cannot fill due to the shortage.
However, the issue goes beyond individual health concerns. The episode also reveals that more than 90% of prescriptions in the US are dependent on imports from India and China, raising questions about national security. Is America’s dependence on China, considered a foreign adversary, putting its citizens at risk?
Dr. Phil Primetime features an interview with Dan Izhaky, CEO of United Safety Technology, who took on the task of producing PPE in America during the Covid pandemic and received significant government support. However, Izhaky now faces challenges competing with Chinese companies backed by the Chinese government.
The show also includes the insights of China-US relations expert and President of The Jamestown Foundation, Peter Mattis, who offers a cautionary perspective on the intentions and capabilities of the Chinese government.
Don’t miss DR PHIL PRIMETIME: Our Dangerous Dependency On China, airing Thursday, August 15, 2024, at 8:00 PM on Merit Street Media.
